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Activities Against Respiration and Cation Transport
in Escherichia coli
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Abstract
Aims: Carbon monoxide (CO) delivered to cells and tissues by CO-releasing molecules (CO-RMs) has beneficial
and toxic effects not mimicked by CO gas. The metal carbonyl Ru(CO)3Cl(glycinate) (CORM-3) is a novel, potent
antimicrobial agent. Here, we established its mode of action. Results: CORM-3 inhibits respiration in several
bacterial and yeast pathogens. In anoxic Escherichia coli suspensions, CORM-3 first stimulates, then inhibits
respiration, but much higher concentrations of CORM-3 than of a classic protonophore are required for stim-
ulation. Proton translocation measurements (H+/O quotients, i.e., H+ extrusion on pulsing anaerobic cells with
O2) show that respiratory stimulation cannot be attributed to true ‘‘uncoupling,’’ that is, dissipation of the
protonmotive force, or to direct stimulation of oxidase activity. Our data are consistent with CORM-3 facilitating
the electrogenic transmembrane movement of K+ (or Na+), causing a stimulation of respiration and H+ pumping
to compensate for the transient drop in membrane potential (DJ). The effects on respiration are not mimicked by
CO gas or control Ru compounds that do not release CO. Inhibition of respiration and loss of bacterial viability
elicited by CORM-3 are reversible by white light, unambiguously identifying heme-containing oxidase(s) as
target(s). Innovation: This is the most complete study to date of the antimicrobial action of a CO-RM. Note-
worthy are the demonstration of respiratory stimulation, electrogenic ion transport, and photosensitive activity,
establishing terminal oxidases and ion transport as primary targets. Conclusion: CORM-3 has multifaceted
effects: increased membrane permeability, inhibition of terminal oxidases, and perhaps other unidentified
mechanisms underlie its effectiveness in tackling microbial pathogenesis. Antioxid. Redox Signal. 19, 497–509.
Introduction
Carbon monoxide (CO) is an environmental pollutantand poison but, in biology and medicine, only the reac-
tions of CO with hemes (3,9) are generally appreciated.
However, CO, similar to nitric oxide and hydrogen sulfide, is
also a ‘‘gasotransmitter’’ with wide-ranging benefits, includ-
ing vasodilation, antioxidant effects, and roles in inflamma-
tory signaling (40). Administration of CO to animals exposed
to endotoxin decreases inflammation and attenuates injury
(3). CO enhances phagocytosis of heat-killed Escherichia coli
(44) by RAW 264.7 cells, and CO from the CO-releasing
molecule-3 [Ru(CO)3Cl(glycinate), CORM-3] decreases Pseu-
domonas aeruginosa counts in the spleen, allowing increased
survival in mice following experimental bacteremia (15).
Moreover, heme oxygenase (HO)–deficient mice suffer
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exaggerated lethality from polymicrobial sepsis (7) and
targeting HO-1 to blood vessels and bowel ameliorates sepsis-
induced death. Importantly, injection of CO-RM into wild-
type mice increases phagocytosis of Enterococcus faecalis and
rescues HO-1-deficient mice with experimental sepsis (7).
Thus, CO administration may be a clinically useful interven-
tion in microbial infections (6,40).
Nevertheless, the mode(s) of action of CO and CO-RMs
remain unclear. We have shown that CORM-3 enters cells,
delivers CO to intracellular oxidases (11), and inhibits bac-
terial growth. In addition, transcriptome profiling of the
response of E. coli to CORM-3 reveals downregulated ex-
pression of respiratory genes; however, the modularity and
redundancy of bacterial respiration (47) suggests that a
functioning respiratory system would persist (11), so the im-
pact on respiration remains uncertain. Evidence for previ-
ously unrecognized activity of CO in bacteria comes from the
transcriptomic effects on genes involved inmetal metabolism,
homeostasis, and transport (11). Probabilistic modeling (52) of
the microarray data identified the involvement of eight tran-
scription factors (11), only two of which (ArcA and FNR) have
direct roles in regulation of respiration. In another tran-
scriptomic study, using tricarbonyl dichlororuthenium (II)
dimer (CORM-2), respiratory genes were not major targets
(42). Intriguingly, although solutions of CO gas also impair
bacterial growth (43), they do not match the effectiveness of
CORM-2 or CORM-3 (11).
Here, we describe for the first time direct evidence for
‘‘classical’’ inhibition of respiration by any CO-RM. That the
action of CO-RM-derived CO is due to binding of CO to he-
moproteins is demonstrated by photorelief of respiratory in-
hibition and bacterial killing. We also demonstrate transient
stimulation of respiration similar to the ‘‘uncoupler’’-like ac-
tion of CORM-3 on mitochondria recently reported (22).
However, we attribute it not to protonophore activity, but to
facilitation of cation transport.
Results
CORM-3 both stimulates and inhibits
bacterial respiration
CO release from CORM-3, using dithionite-reduced myo-
globin as a CO trap, is complete in < 10min (8,38). However,
recent measurements with myoglobin in the absence of
dithionite (which greatly enhances CO release) or oxyhemo-
globin as a trap for the released CO show that CORM-3 lib-
erated no detectable CO in 1 h (38). A previous study,
however, revealed that high CORM-3 concentrations (125–
250 lM) dramatically inhibited E. coli respiration within
30min, whereas 30 lM CORM-3 elicited major changes in
transcript levels within 15min (11).
We, therefore, investigated whether CORM-3 inhibits res-
piration in a timeframe that is consistent with the rapid loss of
CO in certain biological experiments. E. coli cells were incu-
bated in an O2 electrode chamber, and CORM-3 was added
before O2 exhaustion (c. 100 lM O2; Fig. 1). On anoxia (max-
imum CO:O2 ratio), the chamber was opened, allowing in-
ward diffusion of air. Under these ‘‘open’’ conditions, the
respiration rate is given as follows (13,14):
r¼K(TGTL)dTL=dt, (1)
where vr is the respiration rate; K is a rate constant that is
dependent on reaction volume, surface area, temperature,
and others; TG is the concentration of O2 in the buffer when
equilibrated with the gas phase; and TL is the concentration of
O2 in the liquid sample at time t. Thus, at a constant rate of O2
entry from the atmosphere, governed by the stirrer and
liquid/air interface, inhibition or stimulation of respiration is
indicated by an increase or decrease, respectively, in the
measured O2 tension.
Unexpectedly, addition of CORM-3 (100lM final concen-
tration) in the closed phase of the measurement (Fig. 1A,
shaded portion) did not inhibit, but instead stimulated res-
piration by 36.8% (mean value of 34.7%, SEM 6.46%, four
determinations in two biological repeats). After the chamber
was opened, stimulation was still observed, here as a de-
pression of the electrode trace (Fig. 1A, curved solid line)
when compared with the no-CORM-control (dashed line).
However, *20min after CORM-3 addition, inhibition of
respiration was observed as the electrode trace increased
above the steady-state level of the control. Thus, prolonged
respiration measurements in the open system reveal an initial
phase of respiratory stimulation, followed by inhibition.
As the CORM-3 concentration was increased to 250lM
(Fig. 1B) then 500lM (Fig. 1C), the initial stimulation in the
closed system increased slightly (up to 49.8% stimulation,
SEM 3.53%), and inhibition occurred progressively earlier
after CORM-3 addition.
CORM-3 inhibition of bacterial respiration
is enhanced by prior anoxia
Maximal inhibition of respiration is expected when the
CO:O2 ratio is increased, as CO is a competitive inhibitor of O2
binding (28). We, therefore, modified the method to allow
increased anoxic contact between the CO-RM and cells. In the
absence of CORM-3, opening the chamber after brief anoxia
(Fig. 2A, dashed line) results in a steady-state O2 tension, as
constant respiratory O2 consumption is balanced by inward
O2 diffusion. However, when 100 lM CORM-3 was added at
anoxia and the chamber opened immediately (Fig. 2A, solid
line), respiration was initially stimulated (O2 trace below the
control level), then inhibited (O2 trace above the control level).
Increasing the period during which cells were incubated with
CORM-3 from 0min (Fig. 2A) to 10min (Fig. 2B) or 20min
Innovation
Carbon monoxide–releasing molecules (CO-RMs) are
being investigated for potential use in delivering CO to
cells and tissues and show promising early results as an-
timicrobial agents. Since the modes of CO-RM action are
probably dissimilar to currently used antibiotics, CO-RMs
have the potential for topical or targeted treatment of an-
tibiotic-resistant bacteria. However, rational design and
exploitation of CO-RMs requires a fundamental under-
standing of their activity. We report that Ru(CO)3Cl(gly-
cinate) has complex, time-dependent effects on bacteria,
including stimulation and inhibition of respiration, and
promotion of transmembrane cation transport, highlight-
ing the potential of CO-RMs for multifaceted, broad-
spectrum utilization in clinical microbiology.
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(Fig. 2C) before re-admitting O2 progressively increased the
degree of subsequent respiratory inhibition. Thus, when air
was admitted immediately after CORM-3 addition, the mean
inhibition was 41.4% – 3.58%; after 10min, this rose to
53.7%– 1.46% and, at 20min, the inhibitionwas 61.2%– 2.63%.
These increases in inhibition were accompanied by a less
marked phase of respiratory stimulation. The sequence of
stimulation then inhibition, only the latter being anticipated
from CO biochemistry, is not measurable in conventional
short-term O2 measurements.
To test the possibility that the phase of respiratory inhibi-
tion is accompanied by diversion of electrons to O2 via non-
oxidase routes, thus generating superoxide and peroxide [as
in Campylobacter jejuni (59)], we added catalase during the
inhibitory phase of an experiment which was similar to that
shown in Figure 2A. No perturbation of the O2 trace was
observed (Supplementary Fig. S1; Supplementary Data are
available online at www.liebertpub.com/ars), indicating a
lack of significant hydrogen peroxide accumulation.
CORM-3-mediated ‘‘uncoupling’’ of respiration?
CORM-3 (1–20 lM) ‘‘uncouples’’ mitochondrial respiration
(22,50), deduced from the stimulation of respiration in State 2
[i.e., the respiration that occurs on addition of substrate to
mitochondria, but limited by lack of adenosine diphosphate
(ADP) (41)]. CORM-3 also decreasedmitochondrial membrane
potential (DJ). Both changes were gradual and slight com-
pared with the instantaneous effects of only 1lM (or lower)
carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone
(FCCP) (41). Such compounds, generally referred to as ‘‘un-
couplers,’’ are better described as protonophores, catalyzing
the net electrical uniport of H+ and thus increasing the H+
conductance of the membrane (41). However, the possible
protonophore activity of CORM-3 was not directly tested
(22,50).
Bacterial membranes are not known to possess the un-
coupling proteins or adenine nucleotide transporters im-
plicated in the modest ‘‘uncoupling’’ of mitochondria by
FIG. 1. Ru(CO)3Cl(glycinate) (CORM-3) both stimulates
and inhibits bacterial respiration in a concentration-
dependent manner. O2 utilization in a suspension of E. coli
K-12 cells is represented as O2 tension versus time. Bacteria
were suspended in 50mM Tris buffer (pH 7.5), and respira-
tion was stimulated by addition of 5mM glycerol. Shaded
and unshaded sections indicate respiration traces recorded
from the closed and open chamber, respectively. CORM-3
was added to a respiring suspension of E. coli at 50% air
saturation (arrow) in the closed chamber. Dashed (before
CORM-3 addition) and dotted (after CORM-3 addition) lines
show extrapolated traces that highlight the change in gra-
dient after the addition of compound. Rates of respiration (vr:
nmol$min - 1) are shown for each trace. The effects of 100lM
(A), 250lM (B), and 500lM (C) CORM-3 on bacterial res-
piration are shown (1.16mg cell protein). The control
(nothing added) is shown as a dashed line. Traces are rep-
resentative of ‡ 2 biological replicates with a maximum of
three technical repeats per experiment.
FIG. 2. Inhibition of bacterial respiration is more potent
after anoxic cell incubation with CORM-3. O2 utilization in
a suspension of E. coli K-12 cells is represented as O2 tension
versus time. The experimental design is as for Figure 1, except
that, after complete consumption of O2, nothing (control,
dashed line) or 100 lM CORM-3 (arrow, solid line) were ad-
ded to the chamber and the lid was removed (A) immedi-
ately (1.17mg cell protein), (B) after 10min (0.8mg cell
protein), or (C) after 20min (0.8mg cell protein). Rates of
respiration (vr: nmol$min
- 1) are shown for each trace. Traces
are representative of three biological replicates.
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CORM-3 (22); so, we sought direct evidence by measuring
H + translocation using Mitchell’s oxidant pulse technique
(39). Here, a bacterial (or mitochondrial) lightly buffered
suspension becomes anoxic by substrate oxidation. Respira-
tion is re-initiated by injecting a known amount of O2, and H
+
efflux (driven by H + pumps or vectorial chemistry) is re-
corded with a micro-pH electrode. Protonophores such as
FCCP and carbonyl cyanide m-chlorophenylhydrazone
(CCCP) collapse the measured H + extrusion.
Figure 3A shows H + pulses from E. coli cells in a medium
containing K+ plus valinomycin (a K + -specific ionophore)
and SCN - (a permeant anion) to increase the rate and extent
of H + pumping by neutralizing the thermodynamic back-
pressure of the DC. Successive additions of air-saturated
150mM potassium chloride (KCl) elicited acidification of the
bulk medium due to respiration-driven H + translocation.
H +/O ratios, calculated after calibration with anoxic hydro-
chloric acid (HCl), were*3 (mean 2.65 – 0.11), that is, within
the range of values reported for E. coli cells (33,48). Treatment
of cells with the protonophore CCCP (35), which acts similar
to FCCP, before O2 additions dramatically reduced the H
+
pulses due to rapid H + exchange across the bacterial mem-
brane (i.e., true ‘‘uncoupling,’’ Fig. 3B).
In contrast, previous treatment with CORM-3, followed by
pH readjustment to compensate for loss of a H + from the
CO-RM on addition to buffer, resulted in only a modest
concentration-dependent reduction in theH+/O ratio. CORM-3
at 20lM (Fig. 3C) or 100lM (Fig. 3D) attenuated only mar-
ginally the H +/O ratios (mean H +/O= 2.51– 0.06, H +/O=
2.56 – 0.07, respectively). Inactive CORM-3 [iCORM-3, i.e.,
CORM-3 that was allowed to lose CO and then flushed with
N2 to displace CO from solution (8,22)] was without effect
(Supplementary Fig. S2). In addition to measuring H+/O
ratios, wemeasured the rate of H+ backflow after the O2 pulse
in the absence and presence of 20lM CORM-3 and iCORM-3.
In both cases, the t½, measured from semi-log plots of pH
changes were not significantly lowered by CORM-3 (1.45min
for CORM-3 and 1.66min for corresponding control pulses;
for iCORM-3 1.47min and corresponding control pulses
1.57min) (Supplementary Fig. S3).
Addition of 10 lM CCCP to an open O2 electrode elicited
the same downward deflection of the aerobic steady state (i.e.,
stimulation of respiration; Fig. 3E) as that seen with 100 lM
CORM-3 (cf. Fig. 2A). Cell viability was unaffected over
60min by CCCP. Thus, CCCP, but not CORM-3, is a proto-
nophore in E. coli cells, stimulating respiration rates and col-
lapsing respiration-driven H + translocation.
Membrane potential is not dissipated by CORM-3
The transmembrane pH gradient (DpH) and Dw together
constitute the protonmotive force (pmf). Protonophores
shuttle H + across the lipid bilayer, effectively short-circuiting
the transmembrane H + gradient and transiently stimulating
respiration when electron transport is coupled to H + trans-
location (41). Protonophores dissipate both the DpH and Dw
components of the pmf. To determine whether CORM-3 af-
fects the Dw of respiring E. coli, CORM-3 (100lM) was pre-
incubated with cells (for 0–20min) and the Dw determined
(Fig. 4). Under the experimental conditions used here, the
external pH is buffered at pH 7.5, and, therefore, the total
pmf is predominantly Dw. The Dw of untreated cells was
FIG. 3. CORM-3 is not a true ‘‘uncoupler’’ or proto-
nophore. Bacteria were added to lightly buffered solution
in a closed chamber, followed by immediate addition of
valinomycin (22 lM) and stimulation of respiration (1mM
glycerol). The experiment commenced after complete con-
sumption of O2. Arrows show additions of air-saturated
150mM potassium chloride (30C, 11 ng-atom O), each of
which is immediately followed by H + efflux (acidification,
upward deflection). The H +/O ratio for each pulse is shown.
(A) Representative control pulses [no carbon monoxide–
releasing molecule (CO-RM) added] (5.43mg cell protein),
mean H +/O= 2.65 – 0.11, 9 determinations; (B) pulses after
addition of 4 nmol (1.6 lM) carbonyl cyanide m-chlor-
ophenylhydrazone (CCCP) (5.43mg cell protein); (C) 20lM
CORM-3 (5.64mg cell protein), mean H +/O = 2.51 – 0.06, 13
determinations (1.2% lower than control); and (D) 100lM
CORM-3 (5.43mg cell protein), H +/O = 2.56 – 0.07, 15 de-
terminations (3.4% lower than control). Data are represen-
tative of three biological replicates, with ‡ 3 technical repeats
per experiment. Panel (E) shows the effect of 10 lM CCCP
added to E. coli suspended in 50mM Tris (pH 7.5) (0.91mg
cell protein) after complete consumption of O2 in an elec-
trode chamber. The chamber was opened immediately after
addition of compound (arrow), and the effect of 10lM CCCP
(solid line) was compared with the control (nothing added,
dashed line). Rates of respiration (vr: nmol$min
- 1) are shown
for each trace. Traces are representative of the given number
of determinations from three biological replicates.
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111 – 15mV (Fig. 4). Cells treated with CORM-3 had a Dw of
116 – 27mV (range 95–143mV); thus, the CO-RM has a
mild stimulatory effect on the Dw, but did not dissipate theDw
even with 20min of incubation (Fig. 4). Cells treated with
the control molecule RuCl2(DMSO)4 (100lM) had a Dw of
105 – 10mV. These data demonstrate directly that CORM-3
does not dissipate the Dw of respiring cells.
CORM-3 does not directly stimulate oxidase activity
Havingdemonstrated that the stimulatory effect of CORM-3
cannot be attributed to protonophore activity, we investi-
gated other potential mechanisms. Interestingly, low doses
of CO (10lM) transiently stimulate cytochrome c oxidase
activity in mitochondria; however, the overall effects on or-
ganelle or cell respiration were not reported (49). To eliminate
transmembrane ion fluxes from consideration here, respira-
tion of isolated membranes, not bacterial cells, was measured.
When bacteria are disrupted by harsh physical methods such
as ultrasonication, membranes are fragmented and form
‘‘leaky’’ vesicles of mixed orientation that are unsuitable for
transport measurements (41,46). We measured respiration in
such vesicles using both open and closed electrode systems
(Fig. 5). In the conventional closed system, addition of high
concentrations of CORM-3 (400 lM) were required to inhibit
initial rates of respiration by > 50% (Fig. 5A). In the open
system, which allowed more protracted measurements and
CO-RM addition at low (35 lM) poised O2 levels (Fig. 5B),
respiration was reduced to one-third of the control rate by
CORM-3 (100lM). Importantly, in neither experiment was
stimulation of respiration observed, suggesting that this
phenomenon is associatedwith ion fluxes rather than catalytic
function of the quinol oxidases.
K+ and Na+ , not H+ , transport is facilitated by CORM-3
Membrane channels other than those for H + are modified
by CO and CO-RMs in eukaryotic cells. The effect may be
indirect, caused by an interaction between critical Cys res-
idues with reactive O2 species generated from CO inhibi-
tion of mitochondrial respiration (56) or by a direct
interaction between CO and channel proteins (21). CORM-2
is an allosteric inhibitor of voltage-gated K + channels, re-
ducing the voltage dependence of the opening transition
(24). We, therefore, tested whether CORM-3 promotes cat-
ion transport using osmotic swelling of spheroplasts (18).
Iso-osmotic sucrose (0.5 M) provides support to detergent-
and osmotically-sensitive spheroplasts, as shown by
constant light-scattering properties (18). For swelling
to occur, both cation and anion should enter to prevent
charge imbalance; water follows, causing the spheroplasts
to swell.
Spheroplast behavior in iso-osmotic solutions of NO3
-
salts is shown in Figure 6A; the NO3
- anion freely permeates
the spheroplast membrane (18). Iso-osmotic potassium nitrate
(KNO3) (0.25M) provided osmotic support until spheroplasts
FIG. 4. Effects of CORM-3 and RuCl2(DMSO)4 on trans-
membrane potential of E. coli cell suspensions. CORM-3
and RuCl2(DMSO)4 (100lM each) were preincubated aero-
bically with glycerol-energized cells for 20min before mea-
surement of the Dw. Technical replicates were performed on
all samples, and the standard error of the mean across a
number of experiments is shown.
FIG. 5. CORM-3 does not directly stimulate respiratory
oxidase activity. E. coli membrane particles resuspended in
Tris-HCl buffer were added to an O2 electrode chamber to a
final concentration of 170lg/ml. Respiration was stimulated
by the addition of nicotinamide adenine dinucleotide at final
concentrations of 6.25mM (A) or 12.5mM (B). Panel (A)
shows O2 consumption in a closed chamber. CORM-3
(400lM, solid line) was added at *75% air saturation
(155lM O2) (arrow). Panel (B) shows O2 consumption in an
open chamber. The O2 concentration of the suspension was
allowed to equilibrate at *18% air saturation (35lM O2),
and CORM-3 (100 lM, solid line) was added 2min after a
steady-state had been reached (arrow). O2 consumption in the
absence of the compound (dashed line) is also shown for
both experiments. Rates of respiration [vr: nmol$min
- 1$(mg
protein) - 1] in (A) at 2min and (B) at 10 and 20min after the
addition of CORM-3, or at the equivalent time points in the
control experiment, are shown. For both types of experi-
ments the traces are typical of two biological repeats, with
three technical replicates per experiment.
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were treated with valinomycin (Fig. 6A). This effect was
mimicked, although more slowly, by 100lM CORM-3,
showing it to have ionophore-like properties (Fig. 6A), but
iCORM-3 did not promote spheroplast swelling (Fig. 6A).
When spheroplasts were suspended in 0.25M sodium nitrate
(NaNO3), further addition of the Na
+ ionophore X-537A
(lasalocid) or of CORM-3 was required for swelling (Fig. 6A)
despite the facile permeation of the NO3
- anion. X-537A
promotes transport of a number of monovalent and divalent
cations, including Na + , in an electroneutral exchange with
H + (26,41). A solution of CO gas (final concentration 100 lM)
did not promote swelling (Fig. 6A), indicating that CO alone
does not act as an ionophore for Na + ions.
Spheroplast behavior in iso-osmotic solutions of NO2
-
salts is shown in Figure 6B; the NO2
- anion also freely
permeates spheroplasts (18). Thus, in iso-osmotic 0.25 M
potassium nitrite (KNO2), swelling was again promoted by
either valinomycin or CORM-3 (Fig. 6B), as both nitrous acid
(HNO2) and the NO2
- anion can cross the membrane (18).
The K+ , Na + , H + , NO3
- , and NO2
- movements respon-
sible are shown in Figure 6C along with the activities of es-
tablished ionophores. Based on these data, CORM-3 simulates
the effects of K+ and Na + ionophores.
Ru compounds that do not release CO, or CO gas,
do not inhibit respiration
The commonly used CO-RMs have properties other than
CO release that may interfere in biological processes. In par-
ticular, CORM-3 is a Ru carbonyl, Ru being a metal ion with
redox chemistry that does not occur naturally in biology.
Further, CO release may also be accompanied by loss of gly-
cinate, chloride, and other unknown processes and interac-
tions. To demonstrate that the stimulatory and inhibitory
effects of CORM-3 on bacterial respiration are due specifically
to CO release, we used three Ru-containing control molecules.
RuCl2(DMSO)4 is a control for CORM-2, a precursor in
CORM-3 synthesis (8), in which the CO groups are replaced
by DMSO (53). When used at 100 lM (Fig. 7A, solid line),
neither stimulation nor inhibition of respiration was observed
(compare with Fig. 2A). The same result (Fig. 7B, solid line)
was obtained with iCORM-3. Both these compounds are im-
perfect controls: RuCl2(DMSO)4 lacks the glycinate group of
CORM-3, and iCORM has not been exposed to biological
species that induce release of more CO than can be achieved
by gassing. We, therefore, devised a new control (myoglobin-
inactivated CORM-3, miCORM-3) where CO is removed by
two treatments with myoglobin [dissociation constant, CO =
27lM - 1 (58)]. This preparation, when tested with ferrous
myoglobin, gave no detectable CO release (Fig. 7C, inset) and
did not elicit the same response as CORM-3 (Fig. 7C, solid line
compared with gray dotted line). We conclude that CO re-
lease is necessary for the perturbing effects of CORM-3 on
bacterial respiration.
We previously reported (11) that solutions of CO gas were
without effect on E. coli, when used at concentrations equi-
molar with inhibitory levels of CORM-3. Figure 7D–F show
that, irrespective of the period (up to 20min) during which
100 lM CO and cells were incubated anoxically to maximize
the CO:O2 ratio, CO neither stimulated nor inhibited respi-
ration (solid lines). Inmitochondria, amodest increase in State
2 respiration is reported, but only at grossly nonphysiological
(960 lM) CO concentrations (22).
CORM-3 as an antimicrobial agent:
viability loss is coincident with effects on respiration
Earlier, we (15) showed that inhibition of respiration
preceded loss of P. aeruginosa viability, but did not observe
bacterial respiratory stimulation. In the present study, we
sampled from an open O2 electrode chamber to simulta-
neously measure O2 uptake and bacterial viability. On adding
CORM-3 to this low-density culture, an initial phase of re-
spiratory stimulation (downward deflection of the O2 trace)
followed by inhibition (upward deflection)was observed (Fig.
8A) as before (Fig. 2).Within 10min of adding 100lMCORM-3
to a culture, cell viability was reduced by 90% (Fig. 8B) and,
within 20min, the number of viable cells was below the limits
FIG. 6. CORM-3 promotes K1 and
Na1 fluxes across the bacterial mem-
brane. Osmotic behavior of sphero-
plast suspensions (OD500*0.5) in 0.25
M potassium nitrate (KNO3) and so-
dium nitrate (NaNO3) (A), or potas-
sium nitrite (KNO2) (B) was monitored
via light scattering at 500 nm after ad-
dition of 100lM CORM-3, 100lM
iCORM-3, valinomycin, or X-537A
(each 1 lg/ll). (C) CORM-3 facilitates
movement of K + and Na + ions from
the extracellular space (left of mem-
brane) to the cytoplasm (right) through
the cytoplasmic membrane (vertical
lines). Since the NO3
- and NO2
- an-
ions are freely permeable, the pathway
provided by CORM-3 or an estab-
lished ionophore allows swelling.
Traces are representative of ‡ 2 bio-
logical repeats, with three technical
replicates per experiment.
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of detection ( < 9 · 106 cells). These parallel measurements of
O2 tension and viability show that loss of viability began and
was largely completed during the phase of stimulation, before
respiratory inhibition.
Reversal by photolysis of respiratory inhibition
protects cells from CORM-3-induced killing
The photoreversibility of CO inhibition of respiration was
exploited in the classical photochemical action spectrum
approach to identifying terminal oxidases (4). Although
CO-RMs inhibit respiration, and the CO binds to terminal
oxidases (11,15), it has not been demonstrated formally that
respiratory inhibition in vivo is due to CO reactivity with
oxidases. To test this hypothesis, we treated membranes in
a glass chamber with CORM-3 and measured respiration
rates during light–dark cycles (Fig. 9A). Addition of 300lM
CORM-3 inhibited respiration completely when the O2 in the
chamber was reduced to *45lM using N2-saturated buffer
(Fig. 9A). Exposure to actinic light reversed this effect, and
repeated light–dark cycles confirmed that CORM-3 inhibition
was reversible by white light, thus identifying heme oxi-
dases(s) as primary respiratory target(s).
We reasoned that, since cells are killed by CORM-3 during
respiratory perturbations (Fig. 8A, B) and since inhibition of
respiration is light-reversible (Fig. 9A), then cell viability may
be protected from CORM-3 under illumination. This hy-
pothesis is supported by Figure 9B; 30 lM CORM-3 elicited a
drop in cell survival after exposure to actinic light, such that,
at 60min,*30% of the initial viable counts remained. How-
ever, the viability loss was dramatically exacerbated in the
dark; 95% of the population was killed in 60min (Fig. 9B). We
could not determine whether cells ‘‘recover’’ when cultures
are switched from dark to light because the effects of CO-RMs
are not bacteriostatic, but bactericidal as shown in Figure 8
and elsewhere (11,43).
CORM-3 is an inhibitor of respiration
in pathogenic bacteria and yeast
CORM-3 (25–100 lM) inhibited respiration not only of
E. coli but also of P. aeruginosa (Supplementary Fig. S4A), in
which inhibition of growth has previously been reported
(15), and Salmonella enterica serovar Typhimurium (Sup-
plementary Fig. S4B). For P. aeruginosa, the inhibition of
respiration elicited by 25, 50, and 100 lM CORM-3 was
typically 23.7%, 61.7%, and 74.7% *30min after CORM-3
addition. In S. Typhimurium, the inhibition of respiration
elicited by 50lM CORM-3 was typically 74.8% 30min after
addition. Respiratory stimulation was not observed in these
species. Control experiments employing one ormore iCORM-3
compounds [RuCl2(DMSO)4, iCORM-3, and miCORM-3]
showed that only CORM-3 was effective. In S. Typhimurium,
for example, 50lMmiCORM-3 was not a respiratory inhibitor
(Supplementary Fig. S4B). Although CORM-3 also inhibited
respiration of Candida albicans, higher concentrations were re-
quired (250–500lM; Supplementary Fig. S4C) than for bacteria
(Supplementary Fig S4A, B). These concentrations typically
inhibited respiration by 13.4% and 39.0%, respectively. At
lower concentrations (50–100lM), opening the electrode
chamber led to a continuous decline in dissolved O2 due to
uninhibited respiration, which was identical to the control (i.e.,
no CO-RMs added). Again, 250 and 500lM iCORM-3 were
ineffective.
FIG. 7. Ru-containing control molecules and CO have minimal effects on bacterial respiration. O2 utilization in a
suspension of E. coli K-12 cells is represented as O2 tension versus time. Bacteria were suspended in 50mM Tris buffer (pH
7.5), and respiration was stimulated by addition of 5mM glycerol. Shaded and unshaded sections indicate respiration traces
recorded from the closed and open chamber, respectively. CORM-3 control compounds, or CO saturated solution, were
added after complete O2 consumption (arrows). The chamber was opened immediately after injection of control compounds
(solid lines): (A) 100 lM RuCl2(DMSO)4 (0.53mg cell protein); the trace for 100lM CORM-3 in Figure 2A has been super-
imposed for ease of reference (gray dotted line), (B) 100lM inactive CORM-3 (iCORM-3) (0.67mg cell protein), and (C) 50 lM
myoglobin-inactivated CORM-3 (miCORM-3) (0.85mg cell protein); the trace for 50lM CORM-3 is shown for ease of
reference (gray dotted line). Inactivity of miCORM-3 (black line) is shown inset by a lack of CO release to ferrous myoglobin
compared with CORM-3 (gray line). In each panel, black dashed lines represent control traces (nothing added). The effect of
100 lM CO saturated solution (solid lines) after different periods of anoxia is shown in comparison with control (nothing
added, black dashed line): (D) The chamber was opened immediately after addition (0.73mg cell protein), (E) 10min post-
addition (0.73mg cell protein), or (F) 20min post-addition (0.72mg cell protein). Control traces overlaid the traces recorded
after exposure to CO in panels B and C. In each case, traces shown for 100 lM CORM-3 in Figure 2 have been superimposed
for reference (gray dotted line). Traces are representative of ‡ 2 biological replicates.
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Discussion
Utilizing CO gas as an antimicrobial therapeutic (6) is
thwarted by CO toxicity and the systemic delivery methods
necessary (40). CO-RMs allow localized CO delivery, but the
fate of administered CO-RMs is poorly understood. Although
CO-RMs release CO inside bacteria (11,43), we do not un-
derstand the biochemical basis of CO-RM action. In the case of
CORM-2 and ALF062, a contributing factor is the generation
of oxidative stress (61). Here, we demonstrate unequivocally
that CORM-3 is a potent inhibitor of microbial respiration,
and rapid loss of bacterial viability correlates temporally with
the interference of respiratory metabolism (Fig. 8).
CO is widely used as a probe for hemes in biology and
for oxidase identification and studies of ligand binding/
exchange [e.g., (19)]. We previously demonstrated oxidase–
CO adducts in CO-RM-treated cells (11,15) and here show
that such complexes are photolabile at ambient temperatures
with moderate intensities of visible light; photolysis reverses
respiratory inhibition, alleviating the loss of cell viability (Fig.
9). To our knowledge, this is the first evidence that the bio-
logical consequences of CO release from a CO-RM can be
reversed by light, although CO-RMs that release CO on irra-
diation have been described [reviewed in (54)]. These findings
have important implications for future therapeutic applica-
tions of CO-RMs in the light.
Several lines of evidence suggest that the mode of action is
more complex than the release of CO at concentrations equal
to the administered CO-RMs. First, unlike other inhibitors of
bacterial oxidases, for example, cyanide (23,64), inhibition by
CORM-3 in whole cells is slow and not readily observed in a
conventional, closed O2 electrode. This is presumably because
of the need for the CO-RMs to penetrate the cell and interact
with cellular species [e.g., (38)] that displace CO. Respiratory
inhibition is accelerated by preincubating cells with CO-RMs
under anoxic conditions (Fig. 2), thus maximizing the CO:O2
ratio and binding of CO to target hemes, as reported for
hypoxic mitochondria (10).
A further complexity is the stimulation of respiratory rates
that precedes inhibition (Figs. 1 and 2). This can indicate not
only protonophore activity in bacteria as in the case of CCCP
(Fig. 3B) or nisin (12) but also the action of any compound that
catalyzes electrogenic ion movement. As here, Iacono et al.
(22) showed in mitochondria that the effect of CORM-3 was
unlike that of protonophores. First, much higher CO-RM
concentrations (around 2–50lM) were needed than for FCCP
(0.02–1 lM) to observe stimulation of State 2 respiration,
which was more marked and instantaneous with the latter
compound (2.4-fold stimulation with 20lM CORM-3 vs. 6.3-
fold with 1 lM FCCP). Second, mitochondrial Dw was mini-
mally affected byCORM-3 comparedwith FCCP. The effect of
0.02 lM FCCP was similar to that of 20lM CORM-3, whereas
1 lM FCCP collapsed the potential instantaneously. No direct
measurements of H + fluxes accompanying respiratory stim-
ulation, the hallmarks of a classical protonophore, were re-
ported (22), although the ‘‘recoupler’’ 6-ketocholestanol did
not affect mitochondrial stimulation by CORM-3 (22). Fur-
ther, in models of renal function and sepsis, low CORM-3
concentrations increased the respiratory control index, a
measure of the tightness of coupling (31,51). In the present
bacterial case, there was no collapse of the pmf as expected
(Figs. 3 and 4; Supplementary Fig. S3). CO gas slightly en-
hances terminal oxidase activity in mitochondria (1), but not
in E. coli (Fig. 7D–F). We suggest that the term ‘‘uncoupling,’’
to describe CO-RM-promoted respiration, is inappropriate, as
it implies a dissociation (i.e., uncoupling) between the pro-
cesses of respiratory electron transfer and adenosine tripho-
sphate (ATP) synthesis (41), as in the ‘‘uncoupled’’ (unc)
mutants of E. coli with defects in the FoF1 ATP synthase (16).
We conclude that CORM-3 stimulates respiration not by
acting as a protonophore but rather by its transient effects on
ion transport and pmf.
Despite similarities between the effects of CORM-3 on mi-
tochondria (22) and bacteria, there are important differences.
First, the concept of States 2 (ADP-limited) and 3 (ADP-
stimulated) (5) to describe the effects of ADP availability on
respiration tightly coupled to ATP synthesis is not generally
applied to bacteria. Respiratory stimulation in bacteria by
ADP, to which bacteria are impermeable, is not easily dem-
onstrated, although the effects of protonophores can some-
times be observed as a stimulation of respiration (45). ADP/
ATP exchange cannot be measured in fragmented bacterial
membrane vesicles, and intact bacteria are not susceptible to
FIG. 8. CORM-3 elicits cell death at the onset of respi-
ratory effects. Cells were suspended in defined medium in
an O2 electrode chamber at a concentration that was suffi-
cient to result in a steady state at c. 25% air saturation. O2
utilization is represented as O2 tension versus time. E. coli
viability over the course of the experiment was determined
from parallel chamber samples. (A) Effect of 100 lM CORM-
3 (solid line) on O2 uptake in comparison with control
(nothing added, dashed line, 0.31mg cell protein). Arrows
indicate points at which samples were taken to assay via-
bility; solid arrows correspond to the CORM-3-treated sus-
pension; and dashed arrows correspond to the control
suspension. (B) Effect of 100lM CORM-3 (solid line) on vi-
ability in comparison with control (nothing added, dashed
line). Sampling time points are aligned with arrows that
indicate removal of suspension ( panel A) to show the respi-
ratory trace and cell counts in parallel. Traces are represen-
tative of three biological replicates.
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oligomycin used before (22) to block ATP synthase activity.
Further, 5-hydroxydecanoate, an inhibitor of mitochondrial
ATP-dependent K + channels, did not reduce CO-RM-elicited
respiratory stimulation, whereas, in the present study,
CORM-3 was an effective K+ andNa + ionophore (Fig. 6). The
basis of the promoting effect on K+ transport is currently
unclear; E. coli possesses several systems for transport of K+ ,
the major intracellular cation, which is maintained at 0.1–0.5
M. The most attractive candidate may be Kch (30), the first
prokaryotic K + channel to be identified with clear homology
to those eukaryotic voltage-activated K + channels that
CORM-2 modulates (24). A recent report (49) suggests that
CO prevents, not promotes, mitochondrial permeabilization,
thereby preventing swelling, but the effect appears unlinked
to K + permeability.
A probable explanation of the greater effectiveness of CO-
RMs, compared with CO gas, is that the intracellular con-
centrations of CO achieved by CO-RM administration are
significantly higher than for CO gas, despite the facile diffu-
sion of CO through membranes. Based on Ru analysis, the
intracellular level of CORM-3 is > 200lM after adding only
30 lM to growing cultures (11). The preferential release of CO
inside cells is consistent with recent data showing that CO
release rates from CORM-3 are greatly enhanced by sulfite,
but not by a reaction of CORM-3 with globins without such a
ligand (38). In the present work, corroborating evidence for
the requirement of an intracellular or other complex biologi-
cal milieu is provided by Figure 7D–F that fails to show effects
of CO. Further, CO gas did not promote cation transport
(Fig. 6A).
We now propose a ‘‘Trojan Horse’’ mechanism for the an-
timicrobial actions of CO-RMs to explain the potent effects on
respiration that cannot be mimicked by CO gas (Fig. 10). In
brief, a CO-RM may lose its CO permanently in the extracel-
lular milieu through, for example, the presence of a species to
capture the CO or a change in the CO-RM after CO loss. Al-
ternatively, the CO-RM is transported into the cell and con-
centrated (11) carrying its CO cargo (Trojan Horse effect), and
CO dissociation is promoted by a reaction with intracellular
ligands that include sulfite (38). Thus, CO is immediately ac-
cessible at relatively high concentrations to membrane-bound
heme targets, to which it binds. Respiration is inhibited in a
light-reversible manner, and viability is drastically reduced.
Nonheme targets for CO may explain, in part, the diverse
effects of CO and CO-RMs (3,34,40). There are many exam-
ples of nonheme Fe(II) carbonyls, and ligands from amino
acids (S in Cys and N in His) may be targets in voltage-gated
(Slo1 BK) channels that are important in vasodilation (21) or
FIG. 9. Light abrogates the toxic effects of CORM-3 by
photolyzing heme-CO bonds. (A) O2 consumption of E. coli
membrane particles (0.17mg membrane protein) treated
with 300 lM CORM-3. White light focused on the glass
chamber was switched on and off at 2-min intervals (as in-
dicated by the arrows). (B) Viable counts were performed on
cultures of E. coli treated with 30 lM CORM-3 grown either
in light (black bars) or dark (gray bars) conditions. The mean
bacterial survival of five technical repeats at 30, 45, and
60min compared with the viability before the addition of
CORM-3 is shown and is representative of three biological
replicates. Asterisks indicate statistically significant de-
creases in viability of cultures grown in the dark compared
with cultures grown in the light, as measured using the
Student’s t-test (*p < 0.001; **p = 0).
FIG. 10. Trojan Horse hypothesis. It is postulated that CO-
RMs carry their CO ‘‘toxic cargo’’ into the cell interior by
unknown mechanisms. Intracellular accumulation of CO-
RMs and subsequent release of CO leads to CO reaching
concentrations (center of cell) that exceed those which can be
attained by passive diffusion of CO gas from the cell exterior
(bottom left). The major targets of CORM-3 identified in this
work are respiratory electron transfer to O2, catalyzed by
terminal quinol oxidases, and cation transport. Inhibition of
respiration and growth inhibition is reversed by white light
at ambient temperatures (top right). The scheme excludes the
bacterial outer membrane and periplasm and the represen-
tation of the respiratory chain, terminating in a single oxi-
dase, is greatly simplified.
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in bacterial ion channels (Fig. 6). Other nonheme targets
are likely: In Chlamydomonas hydrogenase, CO binds to an
Fe-Fe center (60), and CO also binds to binuclear copper sites
as in tyrosinase (29) and hemocyanins (17,62). Identifying
modes of action is critical if CO and CO-RMs are to be used
therapeutically.
Materials and Methods
Microbial strains and growth conditions
E. coli K-12 MG1655 (RKP5416) (2), P. aeruginosa PAO1
(RKP5417), S. enterica serovar Typhimurium (RKP4901), and a
clinical isolate of C. albicans (CA3153 302, kind gift from
Professor P. Sudbery, The University of Sheffield) were used.
E. coli and S. Typhimurium were grown in defined medium
with glycerol (54mM) (11). P. aeruginosa was grown in mini-
mal M9 medium with glucose (11.1mM) as a carbon source
(15). C. albicans was grown in defined medium containing
D-glucose (111mM) and yeast nitrogen base (6.8 g/L). Bacteria
were grown aerobically in 20–30ml medium in 250ml flasks
fitted with side arms for measurements of optical density with
a Klett meter (red filter) during shaking at 200 rpm and 37C.
CORM-3 and control treatments
Aqueous stock solutions of CORM-3 (25) and RuCl2(DM-
SO)4 (the latter compound supplied by Dr. Tony Johnson,
Chemistry Department, The University of Sheffield) at 10 or
100mM were made fresh each day. iCORM-3 was prepared
(8,22) by dissolving CORM-3 in phosphate-buffered saline
(PBS), allowing CO liberation to the atmosphere for 48 h at
room temperature, and bubbling with O2-free N2 (BOC; GU2
5XY) periodically throughout the incubation to ensure dis-
sociation and loss of CO. miCORM-3 was prepared by treat-
ing CORM-3 twice with a twofold excess of ferrous
myoglobin, prepared by adding sodium dithionite solution
(2.2mM final concentration in 0.1 M potassium phosphate,
pH 7) to 1mM metmyoglobin. Carbonmonoxy myoglobin
was separated from the required inactivated CORM-3 residue
by centrifugation in a Vivaspin 20 concentrator (Sartorius
Stedim Biotech) with a molecular weight cutoff of 5 kDa.
CORM-3 or inactivated CO-RMs were added directly to cells
suspended in medium or 50mM Tris (pH 7.5) in an O2 elec-
trode chamber. COwas added as a solution saturatedwith the
gas by bubbling from a cylinder (BOC) at room temperature.
CO release from CORM-3 and control molecules to ferrous
myoglobin was assayed (8,38) in a dual-wavelength scanning
spectrophotometer (27). Data were plotted as CO reduced
minus reduced spectra (63).
O2 consumption
Cultures were harvested at midexponential phase, washed,
and resuspended in medium or 50mM Tris buffer (pH 7.5).
Cells were suspended in a stirred Perspex chamber fitted with
a Clark-type polarographic O2 electrode (OXY041A; Rank
Brothers Ltd.; CB25 9DA) at 37C (20). Data were recorded on
a chart reader (REC112; Amersham Pharmacia Biotech) or a
Lab-Trax-4/16 recorder and Data-Trax software (World
Precision Instruments, Inc.). Protein concentrations were
measured using a modified Lowry procedure (37). Respira-
tion was stimulated by the addition of glycerol or nicotina-
mide adenine dinucleotide (NADH). An ‘‘open’’ O2 electrode
system was used in most experiments, in which a stirred
sample is open to the atmosphere, allowing continuous O2
diffusion from the vortex surface into the sample; prolonged
measurements can be made without O2 depletion (14). To
correlate O2 consumption and bacterial viability, cells were
added to the chamber at a low concentration that would result
in a steady-state level of c. 25% air saturation. Samples were
taken and diluted in PBS followed by plating drops (diluted
10 - 5–10 - 8) on nutrient agar for viability counts.
Photosensitivity of respiratory inhibition
and loss of viability elicited by CORM-3
Bacteria were grown in 1 L Luria broth (LB) medium in 2 L
baffled flasks at 37C with shaking at 250 rpm until late ex-
ponential phase. Membranes were prepared (46) and incu-
bated in a glass chamber (RC350 respiration cell; Strathkelvin
Instruments Limited; ML1 5RX) with 1.95ml N2-saturated
buffer (50mM Tris-HCl, 2mM magnesium chloride, and
1mM ethylene glycol tetraacetic acid; 37C), then treated with
300 lM ethylene CORM-3. A microcathode O2 electrode
(SI130; Strathkelvin Instruments Limited) located in the
chamber lid was connected to an O2 meter (Model 781) and
then to a Lab-Trax-4/16 recorder and Data-Trax software as
described earlier. Respiration was stimulated with 12.5mM
NADH. A 150Wprojector bulbwas focused on thewall of the
glass chamber using a convex lens, giving an intensity of
175,000 lux at the vessel surface.
To make parallel measurements of respiration rate and
bacterial viability, bacteria were grown to midexponential
phase (50 Klett units) in definedmedium. Samples (2ml) were
transferred to two parallel glass respiration cells, as described
earlier, and stirred at 37C; one was foil-wrapped, and an
actinic light beam was focused on the other as described
earlier. Samples were taken immediately before addition of
30 lMCORM-3 and at intervals thereafter for viability counts.
Respiration-driven H+ translocation
across the bacterial membrane
The apparatus was based on (32,33) incorporating a sealed,
stirred Perspex chamber fitted with a Clark-type polaro-
graphic O2 electrode (OXY040A; Rank Brothers Ltd; CB25
9DA) at 30C. The lid of the chamber wasmodified to support
a semimicro calomel combined pH electrode (pHC4000;
MeterLab; Radiometer Analytical). The signal from the pH
electrode was taken to a pH/ion meter (PHM240; MeterLab;
Radiometer Analytical) and then to a potentiometric recorder.
E. coli was grown aerobically at 37C and 200 rpm in de-
fined medium supplemented with 0.1% casamino acids to
midexponential phase. Cells were starved by shaking for 2 h
in medium lacking carbon sources, harvested by centrifuga-
tion at 4C, washed twice, and resuspended in cold 150mM
KCl. An aliquot was added to 2.5ml lightly buffered medium
(150mM KCl, 50mM potassium cyanide, and 1.5mM gly-
cylglycine; pH 7; 30C) in the chamber. Valinomycin (Sigma-
Aldrich; 22lM final concentration, added as a methanolic
stock solution) was added immediately after, followed by
1mM glycerol to stimulate respiration. The experiment com-
menced after consumption of O2. Additions of an anoxic
solution of 5mM HCl were used to calibrate the apparatus
(25–75 ng-ion H + ). Pulses of air-saturated 150mM KCl (30C)
(25 ll, 11 ng-atom O) were added to promote respiration-
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driven H + translocation and medium acidification. CCCP
(Sigma-Aldrich; 1.6 lM final concentration) was used as pro-
tonophore. H +/O ratios were calculated from deflections
caused by the acid and O2 pulses.
[3H]methyltriphenylphosphonium iodide accumulation
The Dw of washed cell suspensions optical density (OD600
*1.2) in 50mM Tris buffer (pH 7.5) was determined by
measuring the accumulation of [3H]methyltriphenylpho-
sphonium iodide ([3H]TPMP + , 30–60 Ci/mmol; 10 nM final
concentration, NEN; Life Science Products, Inc.) using fil-
tration assays (0.45-lm cellulose-acetate filters; Sartorius Ste-
dim Biotech) (55) after incubation at 37C. Filters were
washed twice with 2ml of 100mM lithium chloride and dried
for 60min at 40C. Filters were resuspended in 2ml of scin-
tillation liquid, and counts per minute were determined using
an LKBWallac 1214 Rackbeta liquid scintillation counter. The
Dw was calculated from the Nernst equation (Dw = 62 · log
[TPMP]in/[TPMP]out), and an intracellular volume of
2.8 – 0.5 ll per mg of protein was used (57).
Spheroplasts and osmotic swelling measurements
Cells were grown in 400ml LB, harvested at mid-
exponential phase and spheroplasts were prepared (36). Cells
were washed once in 10mM Tris-HCl (pH 7.4) and re-
suspended in 20% (w/v) sucrose containing 33mM Tris-HCl
(pH 8) to an OD600 of c. 0.8. The suspension was stirred gently
at 4C with additions of 0.01ml of 0.1 M ethylenediaminete-
traacetic acid (pH 8) and 1 ll of lysozyme (5mg/ml) (per ml
suspension). Osmotic fragility was checked by 10-fold dilu-
tions into water and measuring decreasing turbidity at
500 nm. When spheroplast formation was complete (no fur-
ther reduction in OD500), they were harvested at 4C, washed
once, and resuspended gently in the same Tris/sucrose buffer
using a loose-fitting hand homogenizer. Osmotic swelling
was studied (18) by following the change in turbidity at
500 nm, using a Cary 50 spectrophotometer (Varian), follow-
ing dilution of spheroplast samples in iso-osmotic 0.25 M
solutions of KNO3, KNO2, or NaNO3. Valinomycin and X-
537A (Sigma-Aldrich; acetonitrile solution) were used at final
concentrations of 1lg/ll.
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Abbreviations Used
Dw¼membrane potential
ADP¼ adenosine diphosphate
ALF062¼ tetraethylammonium molybdenum
pentacarbonyl bromide
ATP¼ adenosine triphosphate
CCCP¼ carbonyl cyanide-m-
chlorophenylhydrazone
CO-RM¼ carbon monoxide-releasing molecule
CORM-2¼ tricarbonyl dichlororuthenium (II) dimer
CORM-3¼Ru(CO)3Cl(glycinate)
FCCP¼ trifluoromethoxyphenylhydrazone
HO¼heme oxygenase
iCORM¼CO-RM from which CO is removed by
allowing CO to escape
LB¼Luria broth
miCORM-3¼CORM-3 from which CO is removed
by reaction with dithionite and
myoglobin
NADH¼nicotinamide adenine dinucleotide
ng-atom(s) O¼ g-atoms oxygen·10-9, equal to nmol
O2 · 2
OD¼ optical density
PBS¼phosphate-buffered saline
pmf¼protonmotive force
TPMP+¼methyltriphenylphosphonium iodide
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